|
|
|
Monday, November 13th |
|
07.00-16.30 |
Registration desk |
|
08.30-08.50 |
Welcome address and introduction
Nils Wahlgren, Stockholm
.
Priorities in Stroke Research for the next decade
Stephen Meairs, Mannheim, Nils Wahlgren, Stockholm
|
|
08.50-10.00 |
Session: Carotid endarterectomy vs angioplasty
Chairpersons: Jesper Swedenborg, Stockholm
Consensus secretary: Konstantinos Kostulas, Stockholm |
|
| 08.50-09.10 |
The SPACE study: Results of the Stent-protected percutaneous angioplasty of the carotid vs endarterectomy study
Michael Hennerici, Mannheim |
|
| 09.10-09.30 |
The EVA-3S study: Results of the Endarterectomy vs angioplasty in patients with symptomatic severe carotid stenosis study
Jean-Louis Mas, Paris |
|
09.30-09.45 |
Critical comment on reports from endarterctomy vs angioplasty trials
Martin Brown, London |
|
09.45-10.00 |
Consensus discussion and statement |
|
10.00-10.30 |
Coffee break |
|
10.30-10.55 |
Special lecture: Strategies to reduce the burden of stroke - the perspective until year 2050
Invited speaker: Markku Kaste, Helsinki |
|
10.55-12.15 |
Session: Antiplatelet therapy
Chairpersons: Anna Czlonkowska, Warsaw
Consensus secretary: Mia von Euler, Stockholm |
|
| 10.55-11.15 |
The ESPRIT study: Results of a randomised trial of combined aspirin + dipyridamole vs aspirin alone after cerebral ischaemia of arterial origin
Ale Algra, Utrecht |
|
| 11.15-11.35 |
The CHARISMA study: Results of a randomised trial of combined aspirin+clopidogrel vs aspirin in high-risk patients with stable cardiovascular disease or multiple risk factors
Werner Hacke, Heidelberg |
|
11.35-11.50 |
Dose of aspirin issue revisited
Natan Bornstein, Tel Aviv |
|
11.50-12.05 |
Critical comment on reports from antiplatelet therapy trials
Gudrun Boysen, Copenhagen |
|
12.05-12.20 |
Consensus discussion and statement |
|
12.20-13.20 |
Lunch and poster exhibition |
|
13.20-14.30 |
Session: Cholesterol lowering therapy
Chairpersons: Eivind Berge, Oslo
Consensus secretary: Nikolaos Kostulas, Stockholm |
|
13.20-13.40 |
The SPARCL study: Results of the Stroke prevention by aggressive reduction in cholesterol levels study
Philippa Lavallée, Paris |
|
13.40-14.00 |
The effect of statins withdrawal in the acute phase of stroke
Manuel Rodriguez Yañez, Santiago de Compostela |
|
14.00-14.15 |
Critical comment on reports from cholesterol lowering studies
Bo Norrving, Lund |
|
14.15-14.30 |
Consensus discussion and statement |
|
14.30-15.00 |
Coffee break |
|
15.00-16.25 |
Session: Secondary prevention after stroke and TIA - special issues
Chairpersons: David Russell, Oslo
Consensus secretary: Christina Sjöstrand, Stockholm |
|
| 15.00-15.20 |
Secondary prevention after dissection – anticoagulants or antiplatelets?
John Norris, London |
|
15.20-15.40 |
Secondary prevention and patent foramen ovale - anticoagulants, antiplatelets, closure?
Heinrich Mattle, Bern |
|
| 15.40-16.00 |
The RESQUE study: Results from a descriptive study of management of patients with recurrent cerebrovascular events
Magnus von Arbin, Stockholm |
|
16.00-16.15 |
Critical comment |
|
16.15-16.30 |
Consensus discussion and statement |
|
16.30-16.35 |
Summary and closing of the first day of the meeting, original programme
Nils Wahlgren, Stockholm |
|
| |
All participants are welcome to the following satellite session: |
|
16.35-17.50 |
SITS investigators' open session |
|
16.35-17.00 |
Results from SITS-MOST and SITS-ISTR |
|
16.35-16.45 |
SITS-MOST and SITS-ISTR recruitment, report and acknowledgements of excellent performances
Nils Wahlgren, Stockholm |
|
16.45-17.00 |
SITS-MOST extended report
Nils Wahlgren, Stockholm |
|
17.00-17.20 |
Implementation of stroke treatments in different parts of the world |
|
17.00-17.10 |
Implementation of stroke teatments: Example Armenia
Ruben Tamazyan, Yerevan |
|
17.10-17.20 |
Implementation of stroke treatments: Example Belgium
Geert Vanhooren, Brügge |
|
17.20-17.50 |
Ongoing and planned activitites |
|
17.20-17.30 |
SITS is not just thrombolysis, future plans
Nils Wahlgren, Stockholm
|
|
17.30-17.40 |
About ECASS 3 - ongoing trial
Markku Kaste, Helsinki
|
|
17.40- 17.50 |
About IST-3 - ongoing trial
Veronica Murray, Stockholm |
|
19.30 |
Gala Dinner at Berns - Berzelii Park
The Karolinska Stroke Award 2006 for Excellence in Stroke Research will be announced during the dinner.
|
|
|
|
|
Tuesday, November 14th |
|
08.30-08.35 |
Introduction to day 2 |
|
08.35-10.05 |
Session: Reperfusion and the role of haemorrhage after thrombolysis
Chairpersons: HG Hårdemark, Uppsala
Consensus secretary: Niaz Ahmed, Stockholm |
|
08.35-08.55 |
SITS-MOST final results, original presentation
Nils Wahlgren, Stockholm |
|
| 08.55-09.15 |
Desmoteplase in acute stroke: Results from the DIAS and DEDAS trials
Antoni Davalos, Badalona |
|
| 09.15-09.35 |
Thrombectomy - evidence from studies of MERCI
Wade S Smith, San Francisco |
|
09.35-09.50 |
Risk of haemorrhage after reperfusion treatment. Overestimated?
Rüdiger von Kummer, Dresden |
|
09.50-10.05 |
Critical comment on studies on reperfusion strategies
Tom Skyhöj-Olsen, Copenhagen |
|
10.05-10.20 |
Consensus discussion and statement |
|
10.20-10.50 |
Coffee break |
|
10.50-11.15 |
Special lecture: From haemophilia to haemorrhagic stroke trials - the story of a potential new stroke treatment, Factor VIIa
Invited speaker: Ulla Hedner, Lund |
|
11.15-12.15 |
Session: The elderly stroke patient
Chairpersons: Sigrun Braekken, Oslo
Consensus Secretary: Johan Lökk, Stockholm |
|
| 11.15-11.35 |
The elderly patients – the problem of lack of evidence from clinical trials of pharmacological intervention and rehabilitation
Yngve Gustafson, Umeå |
|
| 11.35-11,55 |
Pharmacological treatment of the very old stroke patient
Gary Ford, Newcastle |
|
11.55-12.15 |
Consensus discussion and statement |
|
12.15-13.10 |
Lunch and poster exhibition |
|
13.10-13.35 |
Special lecture: The unstable plaque
Invited speaker: Michael Hennerici, Mannheim |
|
13.35-14.50 |
Session: Organised acute stroke care
Chairpersons: Lars Thomassen, Bergen
Consensus secretary: Magnus Thorén, Stockholm |
|
13.35-13.55 |
The main components of stroke unit care: results of a European expert survey
Didier Leys, Lille |
|
13.55-14.15 |
The highly specialised stroke unit - neurologist's view
Risto Roine, Turku |
|
| 14.15-14.35 |
The highly specialised stroke unit - interventionist's view
Tommy Andersson, Stockholm |
|
14.35-14.50 |
Consensus discussion and statement |
|
14.50-15.20 |
Coffee break |
|
15.20-16.30 |
Session: Neuroprotection in acute stroke
Chairpersons: Veronika Skvortsova, Moscow
Consensus secretary: Per Holmberg, Stockholm |
|
15.20-15.40 |
Is neuroprotection needed after reperfusion?
Per Wester, Umeå |
|
| 15.40-16.00 |
Update on hemicraniectomy
Eric Jüttler, Heidelberg |
|
16.00-16.20 |
Update on neuroprotection – any Saints around?
Kennedy R Lees, Glasgow |
|
16.20-16.30 |
Consensus discussion and statement |
|
16.30-16.45 |
Summary and closing of the meeting
Nils Wahlgren, Stockholm |
|
17.00- |
SITS Sweden Investigators' Buffet reception and meeting around?
Click here for the programme for this session!
|
|
